| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |